|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Anemia, Aplastic | |||||
| Fanconi Anemia | |||||
| Hematologic Diseases | |||||
| Leukemia | |||||
| Neoplasms | |||||
| Severe Combined Immunodeficiency | |||||
| Myelodysplastic Syndromes | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Anemia | |||||
| Immunologic Deficiency Syndromes | |||||
| Preleukemia | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia, Hypoplastic, Congenital | |||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| DNA Repair-Deficiency Disorders | |||||
| Genetic Diseases, Inborn | |||||
| Immune System Diseases | |||||
| Infant, Newborn, Diseases | |||||
| Metabolic Diseases | |||||
| Neoplasms by Histologic Type | |||||
| Pathologic Processes | |||||
| Precancerous Conditions | |||||
| 4 | Interventions listed in this trial | ||||
| stem cell transplantation | |||||
| 5 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||